HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

5- ((2,6- dichlorobenzyl)sulfonyl)- 3- ((3,5- dimethyl- 4- ((2- (pyrrolidin- 1- ylmethyl)pyrrolidin- 1- yl)carbonyl)- 1H- pyrrol- 2- yl)methylene)- 1,3- dihydro- 2H- indol- 2- one

inhibits c-Met kinase; structure in first source
Also Known As:
PHA 665752; PHA-665752; PHA665752
Networked: 42 relevant articles (4 outcomes, 7 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Christensen, James G: 9 articles (02/2011 - 11/2003)
2. Medová, Michaela: 3 articles (02/2013 - 10/2010)
3. Zimmer, Yitzhak: 3 articles (02/2013 - 10/2010)
4. Al-Dayel, Fouad: 3 articles (01/2012 - 01/2011)
5. Al-Kuraya, Khawla S: 3 articles (01/2012 - 01/2011)
6. Ahmed, Maqbool: 3 articles (01/2012 - 01/2011)
7. Uddin, Shahab: 3 articles (01/2012 - 01/2011)
8. Hussain, Azhar R: 3 articles (01/2012 - 01/2011)
9. Bavi, Prashant: 3 articles (01/2012 - 01/2011)
10. You, Hanning: 2 articles (01/2015 - 09/2011)

Related Diseases

1. Neoplasms (Cancer)
2. Glioma (Gliomas)
3. Carcinoma (Carcinomatosis)
4. Medulloblastoma
5. Lung Neoplasms (Lung Cancer)

Related Drugs and Biologics

1. erlotinib (CP 358,774)
2. gefitinib (Iressa)
3. Cyclooxygenase 2 (Cyclooxygenase-2)
4. Epidermal Growth Factor Receptor (EGF Receptor)
5. Cisplatin (Platino)
6. Adenosine Triphosphate (ATP)
7. Phosphotransferases (Kinase)
8. Protein-Tyrosine Kinases (Tyrosine Kinase)
9. Proto-Oncogene Proteins c-met
10. Hepatocyte Growth Factor (Growth Factor, Hepatocyte)

Related Therapies and Procedures

1. Heterologous Transplantation (Xenotransplantation)
2. Drug Therapy (Chemotherapy)